PMV Pharmaceuticals, Inc.’s PMVP share price has surged by 7.83%, which has investors questioning if this is right time to ...

Cancer researcher Dr Patrick Soon-Shiong shared a 'highly disturbing' new study suggesting a common virus may be fueling a ...

The complexity of cancer signaling and the resulting ... In addition, mutations are frequently detected in proteins such as p53, KRAS and APC (adenomatosis polyposis coli), which are intrinsically ...

This is the first CSCO Guidelines recommendation for lisaftoclax (APG-2575), making it the only China-developed Bcl-2 ...

Finally, we abrogated lysine acetylation by generating KR (lysine to arginine) mutations at single or multiple sites ... to achieve the desired cellular response and efficacy of p53-mediated cancer ...

However, synthetic lethality presents a promising approach for developing treatments targeting tumors with TP53 mutations. Thymine DNA glycosylase ... reduced the viability of the p53-deficient lung ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

PRRDetect is a new algorithm that identifies tumors with faulty DNA repair, helping doctors tailor cancer treatments more ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.

Johns Hopkins Medicine scientists say they have found a pattern of so-called epigenetic "marks" in a transition state between normal and pancreatic cancer cells in mice, and that the normal cells may ...